Absci Corp. (ABSI)
9.515
+0.68
(+7.64%)
USD |
NASDAQ |
Aug 25, 10:26
Absci Total Liabilities (Quarterly) : 22.79M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 22.79M |
| March 31, 2026 | 23.62M |
| December 31, 2025 | 26.85M |
| September 30, 2025 | 34.65M |
| June 30, 2025 | 36.52M |
| March 31, 2025 | 33.65M |
| December 31, 2024 | 34.48M |
| September 30, 2024 | 33.90M |
| June 30, 2024 | 34.04M |
| March 31, 2024 | 34.79M |
| December 31, 2023 | 58.30M |
| September 30, 2023 | 39.93M |
| Date | Value |
|---|---|
| June 30, 2023 | 38.75M |
| March 31, 2023 | 41.84M |
| December 31, 2022 | 64.25M |
| September 30, 2022 | 46.44M |
| June 30, 2022 | 50.12M |
| March 31, 2022 | 54.96M |
| December 31, 2021 | 60.09M |
| September 30, 2021 | 61.11M |
| June 30, 2021 | 219.96M |
| March 31, 2021 | 159.96M |
| December 31, 2020 | 21.56M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Twist Bioscience Corp. | 226.70M |
| Prime Medicine, Inc. | 209.23M |
| Tenax Therapeutics, Inc. | 8.073M |
| Exicure, Inc. | 10.42M |
| Recursion Pharmaceuticals, Inc. | 297.66M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 268.92M |
| Shareholders Equity (Quarterly) | 246.13M |
| Debt to Equity Ratio | 0.0156 |
| Current Ratio | 10.63 |
| Net Debt Paydown Yield | 0.05% |